We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-3.29%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$14.7B
AUM Growth
+$1.28B
Cap. Flow
+$2.06B
Cap. Flow %
13.96%
Top 10 Hldgs %
12.95%
Holding
676
New
148
Increased
154
Reduced
125
Closed
204

Top Buys

Rank Stock Value
1
AER icon
AerCap
AER
+$213M
2
ADBE icon
Adobe
ADBE
+$164M
3
ADI icon
Analog Devices
ADI
+$162M
4
PAYC icon
Paycom
PAYC
+$128M
5
CRM icon
Salesforce
CRM
+$116M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$189M
2
NVDA icon
NVIDIA
NVDA
+$169M
3
DLTR icon
Dollar Tree
DLTR
+$148M
4
VRT icon
Vertiv
VRT
+$127M
5
DELL icon
Dell
DELL
+$122M

Sector Composition

Rank Sector Weight
1 Technology 22.19%
2 Consumer Discretionary 15.96%
3 Industrials 14.65%
4 Healthcare 13.59%
5 Financials 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COGT icon
451
Cogent Biosciences
COGT
$7.1B
$488K ﹤0.01%
50,000
SYBX
452
DELISTED
Synlogic
SYBX
$472K ﹤0.01%
168,034
VBIV
453
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$464K ﹤0.01%
+696,736
New +$854K
SES icon
454
SES AI
SES
$196M
$454K ﹤0.01%
200,000
AMD icon
455
Advanced Micro Devices
AMD
$767B
$411K ﹤0.01%
+4,000
New +$434K
NAMS icon
456
NewAmsterdam Pharma
NAMS
$3.34B
$411K ﹤0.01%
44,432
-85,115
-66% -$922K
BHIL
457
DELISTED
Benson Hill, Inc.
BHIL
$381K ﹤0.01%
32,857
WGS icon
458
GeneDx Holdings
WGS
$2.32B
$359K ﹤0.01%
98,553
MLYS icon
459
Mineralys Therapeutics
MLYS
$2.41B
$357K ﹤0.01%
37,500
SG icon
460
Sweetgreen
SG
$649M
$326K ﹤0.01%
27,772
-72,228
-72% -$1.01M
HYFM icon
461
Hydrofarm Holdings
HYFM
$9.29M
$217K ﹤0.01%
+17,775
New +$198K
WBD icon
462
Warner Bros
WBD
$67.4B
$213K ﹤0.01%
19,600
-1,380,400
-99% -$17.2M
AFMD
463
DELISTED
Affimed
AFMD
$167K ﹤0.01%
35,000
SRZN icon
464
Surrozen
SRZN
$295M
$150K ﹤0.01%
+20,377
New +$194K
AKLI
465
DELISTED
Akili Inc
AKLI
$150K ﹤0.01%
272,390
-400,110
-59% -$397K
BIOC
466
DELISTED
Biocept, Inc.
BIOC
$147K ﹤0.01%
+117,647
New +$142K
WINT
467
DELISTED
Windtree Therapeutics
WINT
$130K ﹤0.01%
+152
New +$168K
GETR
468
DELISTED
Getaround, Inc.
GETR
$113K ﹤0.01%
+325,000
New +$145K
UBX
469
DELISTED
Unity Biotechnology
UBX
$92.9K ﹤0.01%
+38,695
New +$103K
VAPO
470
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$57.7K ﹤0.01%
+22,811
New +$71.3K
RYM
471
RYTHM Inc
RYM
$47.7M
$28.3K ﹤0.01%
+868
New +$36.1K
MDVL
472
CALL
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$7.47K ﹤0.01%
62,266
-1
-0% -$10
AAOI icon
473
Applied Optoelectronics
AAOI
$11.2B
-396,645
Closed -$2.36M
AAP icon
474
Advance Auto Parts
AAP
$3.36B
-478,235
Closed -$33.6M
ABEO icon
475
CALL
Abeona Therapeutics
ABEO
$425M
-70,000
Closed -$282K

Similar funds

Alyeska Investment Group's Q3 2023 Portfolio in Review

As of Q3 2023, Alyeska Investment Group held 676 positions worth $14.7B, up 9.5% from $13.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Alyeska Investment Group deployed $2.06B of net new capital in Q3 2023, opening 148 new positions and adding to 154 existing holdings. Its largest new stake was Paycom: 419,219 shares worth $109M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was NVIDIA, an estimated $169M trimmed.

  • Alyeska Investment Group's largest Q3 2023 buy was Paycom: 419,219 shares worth $109M.
  • Alyeska Investment Group added most to AerCap in Q3 2023, an estimated $213M increase.
  • Alyeska Investment Group's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $169M.
  • Alyeska Investment Group fully exited Activision Blizzard in Q3 2023, selling an estimated $189M.
  • Alyeska Investment Group's ten largest holdings make up 13% of its $14.7B portfolio in Q3 2023.
  • Alyeska Investment Group opened 148 new positions and closed 204 in Q3 2023.
  • Alyeska Investment Group's portfolio value rose 9.5% quarter-over-quarter to $14.7B.

Based on Alyeska Investment Group's 13F filing for Q3 2023, filed 14 Nov 2023.